Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
MA Pena, JF Horga & P Zapater. (2016) Variations of pharmacokinetics of drugs in patients with cirrhosis. Expert Review of Clinical Pharmacology 9:3, pages 441-458.
Read now
Read now
Anais Vallet-Pichard, Vincent Mallet, Charlotte E Costentin & Stanislas Pol. (2009) Treatment of HBV-related cirrhosis. Expert Review of Anti-infective Therapy 7:5, pages 527-535.
Read now
Read now
Andrés Ruiz-Sancho, Julie Sheldon & Vincent Soriano. (2007) Telbivudine: a new option for the treatment of chronic hepatitis B. Expert Opinion on Biological Therapy 7:5, pages 751-761.
Read now
Read now
Articles from other publishers (23)
Laura Vallés-Saiz, Jesús Ávila & Félix Hernández. (2023) Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice. International Journal of Molecular Sciences 24:13, pages 11144.
Crossref
Crossref
琳 杨. (2023) Clinical Research on LLV Patients with Chronic Hepatitis B. Advances in Clinical Medicine 13:08, pages 13038-13044.
Crossref
Crossref
Hyunyoung Yoon, Jiwoo Han & Kyung Lib Jang. (2022) Hepatitis B Virus X Protein Stimulates Hepatitis C Virus (HCV) Replication by Protecting HCV Core Protein from E6AP-Mediated Proteasomal Degradation. Microbiology Spectrum 10:6.
Crossref
Crossref
Raoul Kenfack-Momo, Sebastien Kenmoe, Guy Roussel Takuissu, Jean Thierry Ebogo-Belobo, Cyprien Kengne-Ndé, Donatien Serge Mbaga, Serges Tchatchouang, Martin Gael Oyono, Josiane Kenfack-Zanguim, Robertine Lontuo Fogang, Chris Andre Mbongue Mikangue, Elisabeth Zeuko’o Menkem, Juliette Laure Ndzie Ondigui, Ginette Irma Kame-Ngasse, Jeannette Nina Magoudjou-Pekam, Jean Bosco Taya-Fokou, Arnol Bowo-Ngandji, Seraphine Nkie Esemu, Diane Kamdem Thiomo, Paul Moundipa Fewou, Lucy Ndip & Richard Njouom. (2022) Epidemiology of hepatitis B virus and/or hepatitis C virus infections among people living with human immunodeficiency virus in Africa: A systematic review and meta-analysis. PLOS ONE 17:5, pages e0269250.
Crossref
Crossref
Tshifhiwa Magoro, George Gachara, Lufuno Mavhandu, Emmaculate Lum, Helen K. Kimbi, Roland N. Ndip & Pascal Bessong. (2016) Serologic and genotypic characterization of hepatitis B virus in HIV-1 infected patients from South West and Littoral Regions of Cameroon. Virology Journal 13:1.
Crossref
Crossref
Hye Soo Kim, Beom Kyung Kim, Seung Up Kim, Jun Yong Park, Do Young Kim, Ki Jun Song, Jung Won Park, Yeong Jin Kim, Oidov Baatarkhuu, Kwang-Hyub Han & Sang Hoon Ahn. (2016) Association Between Level of Fibrosis, Rather Than Antiviral Regimen, and Outcomes of Patients With Chronic Hepatitis B. Clinical Gastroenterology and Hepatology 14:11, pages 1647-1656.e6.
Crossref
Crossref
Meng Xu, Wanli Xue, Zhenhua Ma, Jigang Bai & Shengli Wu. (2016) Resveratrol Reduces the Incidence of Portal Vein System Thrombosis after Splenectomy in a Rat Fibrosis Model. Oxidative Medicine and Cellular Longevity 2016, pages 1-7.
Crossref
Crossref
Jiao Yang, Hang Sun & Qi Liu. (2016) The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-Analysis. Gastroenterology Research and Practice 2016, pages 1-11.
Crossref
Crossref
Jiahong Yang, Gao Chen, Xuebing Chen, Hao Zhang, Di Jiang & Guang Yang. (2015) Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure. Virology Journal 12:1.
Crossref
Crossref
Z. Han, Y. Shi, J. Zhu, Y. Chen, F. Yin, L. Xia, G. Luo, Z. Gao, J. Liu, G. Jia, C. Li, X. Zhou & Y. Han. (2013)
Forty‐eight‐week retrospective study of telbivudine and lamivudine treatment in patients with hepatitis
B
‐related cirrhosis
. Journal of Viral Hepatitis 20:s1, pages 58-64.
Crossref
Crossref
Monica C Robotin, Melanie Q Kansil, Jacob George, Kirsten Howard, Steven Tipper, Miriam Levy, Nghi Phung & Andrew G Penman. (2010) Using a population-based approach to prevent hepatocellular cancer in New South Wales, Australia: effects on health services utilisation. BMC Health Services Research 10:1.
Crossref
Crossref
Ayse AlbayrakMuhammet H. UyanikSerkan CerrahSare AltasHakan DursunMehmet DemirHakan Uslu. (2010) Is HMGB1 a New Indirect Marker for Revealing Fibrosis in Chronic Hepatitis and a New Therapeutic Target in Treatment?. Viral Immunology 23:6, pages 633-638.
Crossref
Crossref
Jong Ryul Eun, Heon Ju Lee, Tae Nyeun Kim & Kyeung Soo Lee. (2010) Risk assessment for the development of hepatocellular carcinoma: According to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease. Journal of Hepatology 53:1, pages 118-125.
Crossref
Crossref
Yue Han, Li Hua Huang, Chuan Miao Liu, Shu Yang, Juan Li, Zhi Mei Lin, Xiao Fei Kong, De Min Yu, Dong Hua Zhang, Gen Di Jin, Zhi Meng Lu, Qi Ming Gong & Xin Xin Zhang. (2009) Characterization of hepatitis B virus reverse transcriptase sequences in Chinese treatment naive patients. Journal of Gastroenterology and Hepatology 24:8, pages 1417-1423.
Crossref
Crossref
Monica C. Robotin, Melanie Kansil, Kirsten Howard, Jacob George, Steven Tipper, Gregory J. Dore, Miriam Levy & Andrew G. Penman. (2009) Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening. Journal of Hepatology 50:5, pages 990-998.
Crossref
Crossref
S. Pol. 2009. Post’U FMC-HGE. Post’U FMC-HGE
130
137
.
Susanne Beckebaum, Georgios C. Sotiropoulos, Guido Gerken & Vito R. Cicinnati. (2009) Hepatitis B and liver transplantation: 2008 update. Reviews in Medical Virology 19:1, pages 7-29.
Crossref
Crossref
J. H. Tsai, J. Y. Liu, T. T. Wu, P. C. Ho, C. Y. Huang, J. C. Shyu, Y. S. Hsieh, C. C. Tsai & Y. C. Liu. (2008) Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats. Journal of Viral Hepatitis 15:7, pages 508-514.
Crossref
Crossref
Nabil Ben Chaabane, Hichem Loghmari, Wissem melki, Olfa Hellara, Leila Safer, Fethia Bdioui & Hammouda Saffar. (2008) Hépatites virales chroniques chez les patients insuffisants rénaux. La Presse Médicale 37:4, pages 665-678.
Crossref
Crossref
Monica C RobotinJacob GeorgeRajah SupramaniamFreddy SitasAndrew G Penman. (2008) Preventing primary liver cancer: how well are we faring towards a national hepatitis B strategy?. Medical Journal of Australia 188:6, pages 363-365.
Crossref
Crossref
Heon Ju Lee, Ryul Eun, Byung Ik Jang & Tae Nyeun Kim. (2007) Prevention by Lamivudine of Hepatocellular Carcinoma in Patients Infected with Hepatitis B Virus. Gut and Liver 1:2, pages 151-158.
Crossref
Crossref
R.A. Umar, S.W. Hassan, M.J. Ladan, I.K. Matazu, B. Shehu, R.A. Shehu, L.G. Muhammed & F.I. Molabo. (2007) Adverse Hepatic Effects Associated with Administration of Antiretroviral Drugs (Nevirapine, Lamivudine and Stavudine) to Albino Rats: Implication for Management of Patients with HIV/AIDS. Asian Journal of Biochemistry 3:1, pages 19-25.
Crossref
Crossref
Gabriela Gutierrez-Reyes, Maria Concepcion Gutierrez-Ruiz & David Kershenobich. (2007) Liver Fibrosis and Chronic Viral Hepatitis. Archives of Medical Research 38:6, pages 644-651.
Crossref
Crossref